Cystine/Glutamate Xc – Antiporter Induction Compensates for Transsulfuration Pathway Repression by 2,3,7,8-Tetrachlorodibenzo- p -dioxin (TCDD) to Ensure Cysteine for Hepatic Glutathione Biosynthesis
Chemical Research in Toxicology · 2023
DOI: 10.1021/acs.chemrestox.3c00017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Research in Toxicology, 2023. Verfasst von Karina Orlowska und 4 weiteren Autor:innen. Hauptthemen laut MEDLINE: Polychlorinated Dibenzodioxins, Fatty Liver. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIEHS NIH HHS, National Institute of Environmental Health Sciences, Michigan State University.
Abstract (Originalsprache)
Exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) has been associated with the induction of oxidative stress and the progression of steatosis to steatohepatitis with fibrosis. It also disrupts metabolic pathways including one-carbon metabolism (OCM) and the transsulfuration pathway with possible consequences on glutathione (GSH) levels. In this study, complementary RNAseq and metabolomics data were integrated to examine the hepatic transsulfuration pathway and glutathione biosynthesis in mice following treatment with TCDD every 4 days for 28 days. TCDD dose-dependently repressed hepatic cystathionine β-synthase (CBS) and cystathionine γ-lyase (CTH) mRNA and protein levels. Reduced CBS and CTH levels are also correlated with dose-dependent decreases in hepatic extract hydrogen sulfide (H2S). In contrast, cysteine levels increased consistent with the induction of Slc7a11, which encodes for the cystine/glutamate Xc- antiporter. Cotreatment of primary hepatocytes with sulfasalazine, a cystine/glutamate Xc- antiporter inhibitor, decreased labeled cysteine incorporation into GSH with a corresponding increase in TCDD cytotoxicity. Although reduced and oxidized GSH levels were unchanged following treatment due to the induction of GSH/GSSG efflux transporter by TCDD, the GSH:GSSG ratio decreased and global protein S-glutathionylation levels in liver extracts increased in response to oxidative stress along with the induction of glutamate-cysteine ligase catalytic subunit (Gclc), glutathione synthetase (Gss), glutathione disulfide reductase (Gsr), and glutathione transferase π (Gstp). Furthermore, levels of ophthalmic acid, a biomarker of oxidative stress indicating GSH consumption, were also increased. Collectively, the data suggest that increased cystine transport due to cystine/glutamate Xc- antiporter induction compensated for decreased cysteine production following repression of the transsulfuration pathway to support GSH synthesis in response to TCDD-induced oxidative stress.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
ORCID-Profile: Rance Nault, Timothy R Zacharewski
Förderung
- NIEHS NIH HHS
- National Institute of Environmental Health Sciences
- Michigan State University
Zitieren
APA
Orlowska, K., Fling, R. R., Nault, R., Schilmiller, A. L., & Zacharewski, T. R. (2023). Cystine/Glutamate Xc – Antiporter Induction Compensates for Transsulfuration Pathway Repression by 2,3,7,8-Tetrachlorodibenzo- p -dioxin (TCDD) to Ensure Cysteine for Hepatic Glutathione Biosynthesis. Chemical Research in Toxicology. https://doi.org/10.1021/acs.chemrestox.3c00017
Vancouver
Orlowska K, Fling RR, Nault R, Schilmiller AL, Zacharewski TR. Cystine/Glutamate Xc – Antiporter Induction Compensates for Transsulfuration Pathway Repression by 2,3,7,8-Tetrachlorodibenzo- p -dioxin (TCDD) to Ensure Cysteine for Hepatic Glutathione Biosynthesis. Chemical Research in Toxicology. 2023. doi:10.1021/acs.chemrestox.3c00017
BibTeX
@article{Orlowska2023,
author = {Orlowska, Karina and Fling, Russ R and Nault, Rance and Schilmiller, Anthony L and Zacharewski, Timothy R},
title = {Cystine/Glutamate Xc – Antiporter Induction Compensates for Transsulfuration Pathway Repression by 2,3,7,8-Tetrachlorodibenzo- p -dioxin (TCDD) to Ensure Cysteine for Hepatic Glutathione Biosynthesis},
journal = {Chemical Research in Toxicology},
year = {2023},
doi = {10.1021/acs.chemrestox.3c00017}
}
EUVIMED